Azra AI vs Patients.app (2026)
Both read clinical documents with AI and route what they find to a decision. Azra AI, founded in Tennessee in 2022, reads pathology and radiology reports as they land in the record, identifies newly diagnosed cancers and suspicious findings with clinically trained language models, and turns them into work someone is accountable for. Patients.app, from Granville Labs, finds a patient's records across other hospitals and practices, reaching what it says is 95 percent of US hospitals through national networks as well as the local EMR, PDFs, inboxes and faxes, and screens them for a specific decision, with every result linked to its source. Choose Azra to catch findings that need follow up; choose Patients.app to gather and screen outside records before a decision.
- Cancers and suspicious findings in reports should not fall through the cracks.
- Each finding should become a task someone owns.
- Pathology and radiology reports are the documents that matter.
- You need a patient's records from other hospitals and practices.
- Records should be screened for the specific decision you face.
- Every result should link to its source document.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Azra AI and Patients.app are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Azra AI | Patients.app |
|---|---|---|
| Primary category | Clinical Decision Support | Clinical Summarization & Chart Review |
| Founded | 2022 | Not recorded |
| Headquarters | Nashville, Tennessee, United States | Not recorded |
| Website | azra-ai.com | patients.app |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
Azra AI
-
Acquisition / corporate
Azra AI completed its acquisition of Blackford Analysis, whose platform offers more than 130 imaging AI applications from over 45 partner vendors.
Source -
EHR / interoperability
Azra AI has integrated its care orchestration platform with Blackford's portfolio of over 130 medical imaging AI applications.
Source -
EHR / interoperability
Azra AI has partnered with RevealDx to integrate the mSI score for characterizing suspicious cancerous lung lesions into its oncology platform.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Azra AI reads pathology and radiology reports as they land in the record and turns what it finds into work someone is accountable for. Founded in 2022 in Tennessee by Chris Cashwell, formerly named Invenero Holdings, the company describes clinically trained natural language models that identify newly diagnosed cancers and suspicious incidental findings, and publishes a headline precision figure of 99 percent.
Source: AI Health Index, September 2026
Patients.app, from Granville Labs, finds a patient's records across other hospitals and practices and uses AI to screen them for a specific decision. The company says it reaches 95 percent of US hospitals through national data networks, alongside the local EMR, PDFs, inboxes and faxes, and every result links back to its source document.
Source: AI Health Index, September 2026
Questions buyers ask
How do Azra AI and Patients.app work with the EHR?
For Azra AI, the incidental findings page says radiology reports stream in over HL7 and FHIR from Cerner, Epic or any source system, are processed in real time and routed into care pathways, and that every action is written back so clinicians do not document twice. The oncology product surfaces patients from the record at diagnosis and sends documentation back into it.
With Patients.app, the company says it connects directly to major EMRs, accepts every format from FHIR to fax, reaches 95 percent of US hospitals through national data networks, and can send reports back into the EMR; it also fills UNOS and TIEDI forms for transplant programs. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 30, 2026. No vendor pays for placement.
How are Azra AI and Patients.app priced and sold?
In Azra AI's case, a separate services menu sells people as well as software: strategic execution, clinical and non clinical navigation, tumor board support and cancer registry case finding. The route in is an enterprise review, so this is sold as a platform plus managed services to health systems.
For Patients.app, the product is sold to ambulatory surgery centers, transplant centers and clinical teams, and to health technology companies through an API, with a demo request to start. The home page counts a "guaranteed revenue increase" of 15 percent with no terms. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 30, 2026. No vendor pays for placement.
How do Azra AI and Patients.app handle patient data?
With Azra AI, the privacy policy, last updated March 2026, is a short notice about contact information collected from website visitors and prospective customers, with a generic data security paragraph; it does not address pathology reports, radiology reports or patient data at all.
In Patients.app's case, the privacy policy (modified 27 May 2024, review date 23 Sep 2024) says the AI tools generally use anonymized and aggregated data, but that PHI, including medical records and clinicians' questions, may be accessed to improve products and services, and that anonymized data may be shared with third parties for any purpose, including research and marketing. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 30, 2026. No vendor pays for placement.
Which settings and specialties do Azra AI and Patients.app cover?
For Azra AI, the core is the service line from the report that carries a new cancer diagnosis through navigation, tumor boards, follow up and registry reporting.
With Patients.app, the product targets pre-operative screening at ambulatory surgery centers, transplant candidate evaluation, clinical teams in any record-heavy workflow, and health technology companies through an API. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 30, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers.
Both records were reviewed on this site in September 2026. Neither publishes a price. Patients.app's figure of 95 percent of US hospitals reached is its own.
Ask Azra how often a flagged finding turns out to need no follow up, and ask Patients.app what share of a patient's records it finds.